{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T18:05:45Z","timestamp":1775671545598,"version":"3.50.1"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004695","name":"University of KwaZulu-Natal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004695","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Research Foundation of South Africa","award":["106040"],"award-info":[{"award-number":["106040"]}]},{"DOI":"10.13039\/501100001322","name":"Medical Research Council of South Africa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ejps.2018.10.017","type":"journal-article","created":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T02:19:33Z","timestamp":1539742773000},"page":"121-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["Combination drug therapy via nanocarriers against infectious diseases"],"prefix":"10.1016","volume":"127","author":[{"given":"Pavan","family":"Walvekar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh","family":"Gannimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4968-4779","authenticated-orcid":false,"given":"Thirumala","family":"Govender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2018.10.017_bb0005","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ejps.2010.05.007","article-title":"Arthemeter-loaded lipid nanoparticles produced by modified thin-film hydration: pharmacokinetics, toxicological and in vivo anti-malarial activity","volume":"40","author":"Aditya","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.10.017_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cis.2013.10.014","article-title":"Advances in nanomedicines for malaria treatment","volume":"201","author":"Aditya","year":"2013","journal-title":"Adv. Colloid Interf. Sci."},{"key":"10.1016\/j.ejps.2018.10.017_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/7372306","article-title":"Niosomes as nanoparticular drug carriers: fundamentals and recent applications","volume":"2016","author":"Ag Seleci","year":"2016","journal-title":"J. Nanomater."},{"key":"10.1016\/j.ejps.2018.10.017_bb0020","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1556-276X-8-102","article-title":"Liposome: classification, preparation, and applications","volume":"8","author":"Akbarzadeh","year":"2013","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.ejps.2018.10.017_bb0025","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/AAC.01634-12","article-title":"Efficacy of liposomal bismuth-ethanedithiol-loaded tobramycin after intratracheal administration in rats with pulmonary Pseudomonas aeruginosa infection","volume":"57","author":"Alhariri","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2018.10.017_bb0030","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00436-013-3696-5","article-title":"Therapeutic efficacy of poly (lactic-co-glycolic acid) nanoparticles encapsulated ivermectin (nano-ivermectin) against brugian filariasis in experimental rodent model","volume":"113","author":"Ali","year":"2014","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejps.2018.10.017_bb0035","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/jac\/dkq036","article-title":"Attenuation of Pseudomonas aeruginosa virulence factors and biofilms by co-encapsulation of bismuth\u2013ethanedithiol with tobramycin in liposomes","volume":"65","author":"Alipour","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2018.10.017_bb0040","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.2042-7158.2011.01304.x","article-title":"Bismuth-ethanedithiol incorporated in a liposome-loaded tobramycin formulation modulates the alginate levels in mucoid Pseudomonas aeruginosa","volume":"63","author":"Alipour","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2018.10.017_bb0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1054\/drup.1999.0076","article-title":"HIV resistance to zidovudine: the role of pyrophosphorolysis","volume":"2","author":"Arion","year":"1999","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ejps.2018.10.017_bb0050","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/jps.2600821008","article-title":"Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism","volume":"82","author":"Aungst","year":"1993","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.10.017_bb0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.progpolymsci.2016.04.004","article-title":"Multifaceted polymersome platforms: spanning from self-assembly to drug delivery and protocells","volume":"60","author":"Balasubramanian","year":"2016","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.ejps.2018.10.017_bb0060","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-2836(65)80093-6","article-title":"Diffusion of univalent ions across the lamellae of swollen phospholipids","volume":"13","author":"Bangham","year":"1965","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejps.2018.10.017_bb0065","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1081\/DDC-120039184","article-title":"An explanation for the physical instability of a marketed fixed dose combination (FDC) formulation containing isoniazid and ethambutol and proposed solutions","volume":"30","author":"Bhutani","year":"2004","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2018.10.017_bb0070","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1128\/CMR.14.2.244-269.2001","article-title":"Wound microbiology and associated approaches to wound management","volume":"14","author":"Bowler","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejps.2018.10.017_bb0075","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature17042","article-title":"Antibacterial drug discovery in the resistance era","volume":"529","author":"Brown","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2018.10.017_bb0080","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1023\/A:1015885814417","article-title":"Liposomes and nanoparticles in the treatment of intracellular bacterial infections","volume":"8","author":"Couvreur","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.10.017_bb0085","doi-asserted-by":"crossref","first-page":"6202","DOI":"10.1016\/j.biomaterials.2013.05.012","article-title":"A review of nanotechnological approaches for the prophylaxis of HIV\/AIDS","volume":"34","author":"Date","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2018.10.017_bb0090","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.antiviral.2012.09.015","article-title":"Development and evaluation of a thermosensitive vaginal gel containing raltegravir+ efavirenz loaded nanoparticles for HIV prophylaxis","volume":"96","author":"Date","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejps.2018.10.017_bb0095","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and evolution of antibiotic resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.ejps.2018.10.017_bb0100","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/0020-7519(95)00084-4","article-title":"Antimalarial properties of soy-bean fat emulsions","volume":"25","author":"Deharo","year":"1995","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejps.2018.10.017_bb0105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/1471-2334-9-198","article-title":"Combination antiretroviral drugs in PLGA nanoparticle for HIV-1","volume":"9","author":"Destache","year":"2009","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ejps.2018.10.017_bb0110","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/jac\/dkq318","article-title":"Antiretroviral release from poly (dl-lactide-co-glycolide) nanoparticles in mice","volume":"65","author":"Destache","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2018.10.017_bb0115","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1046\/j.1365-2125.1999.00052.x","article-title":"Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components","volume":"48","author":"Eagling","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2018.10.017_bb0120","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/AAC.44.3.697-704.2000","article-title":"Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria","volume":"44","author":"Ezzet","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2018.10.017_bb0125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1021\/nn900002m","article-title":"Impact of nanotechnology on drug delivery","volume":"3","author":"Farokhzad","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejps.2018.10.017_bb0130","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1097\/QAD.0000000000000421","article-title":"Long-acting three-drug combination anti-HIV nanoparticles enhance drug exposure in primate plasma and cells within lymph nodes and blood","volume":"28","author":"Freeling","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.ejps.2018.10.017_bb0135","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/aid.2014.0210","article-title":"Anti-HIV drug-combination nanoparticles enhance plasma drug exposure duration as well as triple-drug combination levels in cells within lymph nodes and blood in primates","volume":"31","author":"Freeling","year":"2015","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.ejps.2018.10.017_bb0140","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1021\/acs.molpharmaceut.6b00099","article-title":"Nanoparticles encapsulated with LL37 and serpin a1 promotes wound healing and synergistically enhances antibacterial activity","volume":"13","author":"Fumakia","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2018.10.017_bb0145","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0014-5793(73)80394-1","article-title":"Drug entrapment in liposomes","volume":"36","author":"Gregoriadis","year":"1973","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejps.2018.10.017_bb0150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1042\/bj1240058P","article-title":"Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases","volume":"124","author":"Gregoriadis","year":"1971","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejps.2018.10.017_bb0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0009-3084(93)90053-6","article-title":"Chemical stability of liposomes: implications for their physical stability","volume":"64","author":"Grit","year":"1993","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.ejps.2018.10.017_bb0160","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijpharm.2003.10.033","article-title":"Co-encapsulation of isoniazid and rifampicin in liposomes and characterization of liposomes by derivative spectroscopy","volume":"271","author":"G\u00fcrsoy","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.10.017_bb0165","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.nantod.2015.06.006","article-title":"Nanoparticle uptake: the phagocyte problem","volume":"10","author":"Gustafson","year":"2015","journal-title":"Nano Today"},{"key":"10.1016\/j.ejps.2018.10.017_bb0170","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/jac\/dkn422","article-title":"Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa","volume":"62","author":"Halwani","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2018.10.017_bb0175","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijpharm.2008.03.008","article-title":"Liposomal bismuth-ethanedithiol formulation enhances antimicrobial activity of tobramycin","volume":"358","author":"Halwani","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.10.017_bb0180","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijpharm.2009.02.001","article-title":"Bismuth\u2013thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa","volume":"373","author":"Halwani","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.10.017_bb0185","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s11095-008-9765-2","article-title":"Targeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticles","volume":"26","author":"Ham","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.10.017_bb0190","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4155\/tde.10.13","article-title":"Nanoparticle-assisted combination therapies for effective cancer treatment","volume":"1","author":"Hu","year":"2010","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejps.2018.10.017_bb0195","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2011.07.002","article-title":"\u201cNanoantibiotics\u201d: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era","volume":"156","author":"Huh","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2018.10.017_bb0200","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0169-409X(96)00494-2","article-title":"Lipid-based vehicles for the oral delivery of poorly water soluble drugs","volume":"25","author":"Humberstone","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2018.10.017_bb0205","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/08982104.2010.539185","article-title":"Conventional and long-circulating liposomes of artemisinin: preparation, characterization, and pharmacokinetic profile in mice","volume":"21","author":"Isacchi","year":"2011","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ejps.2018.10.017_bb0210","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ejpb.2011.11.015","article-title":"Artemisinin and artemisinin plus curcumin liposomal formulations: enhanced antimalarial efficacy against Plasmodium berghei-infected mice","volume":"80","author":"Isacchi","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2018.10.017_bb0215","doi-asserted-by":"crossref","first-page":"6636","DOI":"10.1016\/j.biomaterials.2014.04.058","article-title":"Parasite impairment by targeting Plasmodium-infected RBCs using glyceryl-dilaurate nanostructured lipid carriers","volume":"35","author":"Jain","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2018.10.017_bb0220","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2008.07.032","article-title":"Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject","volume":"364","author":"Joshi","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.10.017_bb0225","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.colsurfb.2014.02.045","article-title":"Ion pairing with linoleic acid simultaneously enhances encapsulation efficiency and antibacterial activity of vancomycin in solid lipid nanoparticles","volume":"117","author":"Kalhapure","year":"2014","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.ejps.2018.10.017_bb0230","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/jps.24298","article-title":"Nanoengineered drug delivery systems for enhancing antibiotic therapy","volume":"104","author":"Kalhapure","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.10.017_bb0235","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1517\/17425247.2011.543673","article-title":"Potential of polymeric nanoparticles in AIDS treatment and prevention","volume":"8","author":"Khalil","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2018.10.017_bb0240","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/499291a","article-title":"Cancer: calculated treatment","volume":"499","author":"Komarova","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2018.10.017_bb0245","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/QAD.0000000000001405","article-title":"Long-acting combination anti-HIV drug suspension enhances and sustains higher drug levels in lymph node cells than in blood cells and plasma","volume":"31","author":"Kraft","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.ejps.2018.10.017_bb0250","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jconrel.2018.02.003","article-title":"Mechanism-based pharmacokinetic (MBPK) models describe the complex plasma kinetics of three antiretrovirals delivered by a long-acting anti-HIV drug combination nanoparticle formulation","volume":"275","author":"Kraft","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2018.10.017_bb0255","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.msec.2015.10.083","article-title":"Development of PLGA\u2013PEG encapsulated miltefosine based drug delivery system against visceral leishmaniasis","volume":"59","author":"Kumar","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ejps.2018.10.017_bb0260","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrd707","article-title":"Moving smaller in drug discovery and delivery","volume":"1","author":"Lavan","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2018.10.017_bb0265","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3109\/10717544.2014.880756","article-title":"Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant Staphylococcus aureus infection","volume":"22","author":"Li","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2018.10.017_bb0270","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/QAD.0000000000000971","article-title":"Co-delivery of HIV-1 entry inhibitor and nonnucleoside reverse transcriptase inhibitor shuttled by nanoparticles: cocktail therapeutic strategy for antiviral therapy","volume":"30","author":"Li","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.ejps.2018.10.017_bb0275","first-page":"122","article-title":"A review of the structure, preparation, and application of NLCs, PNPs, and PLNs","volume":"7","author":"Li","year":"2017","journal-title":"Nano"},{"key":"10.1016\/j.ejps.2018.10.017_bb0280","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1016\/j.biomaterials.2013.02.028","article-title":"Genipin-cross-linked fucose\u2013chitosan\/heparin nanoparticles for the eradication of Helicobacter pylori","volume":"34","author":"Lin","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2018.10.017_bb0285","first-page":"1","article-title":"Highly bioavailable silibinin nanoparticles inhibit HCV infection","volume":"0","author":"Liu","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.ejps.2018.10.017_bb0290","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI18535","article-title":"Antimicrobial resistance: the example of Staphylococcus aureus","volume":"111","author":"Lowy","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2018.10.017_bb0295","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2018.10.017_bb0300","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1128\/AAC.01428-13","article-title":"Enhanced antimalarial activity by a novel artemether-lumefantrine lipid emulsion for parenteral administration","volume":"58","author":"Ma","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2018.10.017_bb0305","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.micpath.2017.03.014","article-title":"The effect of tobramycin incorporated with bismuth-ethanedithiol loaded on niosomes on the quorum sensing and biofilm formation of Pseudomonas aeruginosa","volume":"107","author":"Mahdiun","year":"2017","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ejps.2018.10.017_bb0310","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2217\/nnm.10.1","article-title":"Emerging nanotechnology approaches for HIV\/AIDS treatment and prevention","volume":"5","author":"Mamo","year":"2010","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.ejps.2018.10.017_bb0315","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/QAD.0000000000001349","article-title":"Tenofovir alafenamide and elvitegravir loaded nanoparticles for long-acting prevention of HIV-1 vaginal transmission","volume":"31","author":"Mandal","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.ejps.2018.10.017_bb0320","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.nano.2014.06.002","article-title":"Application of heparin as a dual agent with antimalarial and liposome targeting activities toward Plasmodium-infected red blood cells","volume":"10","author":"Marques","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejps.2018.10.017_bb0325","first-page":"716","article-title":"Biodegradable polymeric nanoparticles for delivery of combination of antiretroviral drugs","volume":"7","author":"Meshram","year":"2015","journal-title":"Int. J. ChemTech Res."},{"key":"10.1016\/j.ejps.2018.10.017_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/bm501285t","article-title":"Advances in combination therapies based on nanoparticles for efficacious cancer treatment: an analytical report","volume":"16","author":"Mignani","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejps.2018.10.017_bb0335","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/jac\/dkh518","article-title":"Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients","volume":"55","author":"Mugabe","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2018.10.017_bb0340","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4103\/0250-474X.57282","article-title":"Solid lipid nanoparticles: a modern formulation approach in drug delivery system","volume":"71","author":"Mukherjee","year":"2009","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.10.017_bb0345","first-page":"4441","article-title":"Novel targeting of PEGylated liposomes for codelivery of TGF-\u03b21 siRNA and four antitubercular drugs to human macrophages for the treatment of mycobacterial infection: a quantitative proteomic study","volume":"9","author":"Niu","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ejps.2018.10.017_bb0350","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.nano.2015.11.017","article-title":"Development, characterization and antimalarial efficacy of dihydroartemisinin loaded solid lipid nanoparticles","volume":"12","author":"Omwoyo","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejps.2018.10.017_bb0355","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/jac\/dkl128","article-title":"Oral nanoparticle-based antituberculosis drug delivery to the brain in an experimental model","volume":"57","author":"Pandey","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2018.10.017_bb0360","first-page":"357","article-title":"Nanotechnology based drug delivery system (s) for the management of tuberculosis","volume":"44","author":"Pandey","year":"2006","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.ejps.2018.10.017_bb0365","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.tube.2003.07.001","article-title":"Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis","volume":"83","author":"Pandey","year":"2003","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ejps.2018.10.017_bb0370","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.tube.2005.08.009","article-title":"Oral solid lipid nanoparticle-based antitubercular chemotherapy","volume":"85","author":"Pandey","year":"2005","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ejps.2018.10.017_bb0375","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/10717540500398076","article-title":"Chemotherapeutic efficacy of nanoparticle encapsulated antitubercular drugs","volume":"13","author":"Pandey","year":"2006","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2018.10.017_bb0380","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/10717544.2014.905883","article-title":"Development of artemether and lumefantrine co-loaded nanostructured lipid carriers: physicochemical characterization and in vivo antimalarial activity","volume":"23","author":"Parashar","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2018.10.017_bb0385","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jconrel.2016.02.001","article-title":"Development and in vivo evaluation of child-friendly lopinavir\/ritonavir pediatric granules utilizing novel in situ self-assembly nanoparticles","volume":"226","author":"Pham","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2018.10.017_bb0390","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/bmj.317.7159.660","article-title":"Antiviral drug resistance","volume":"317","author":"Pillay","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.ejps.2018.10.017_bb0395","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ijpharm.2016.07.021","article-title":"Artemether-lumefantrine nanostructured lipid carriers for oral malaria therapy: enhanced efficacy at reduced dose and dosing frequency","volume":"511","author":"Prabhu","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.10.017_bb0400","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ijpharm.2016.09.008","article-title":"Nanostructured lipid carriers of artemether\u2013lumefantrine combination for intravenous therapy of cerebral malaria","volume":"513","author":"Prabhu","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.10.017_bb0405","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12639-012-0174-4","article-title":"Immunological disturbances associated with malarial infection","volume":"37","author":"Pradhan","year":"2013","journal-title":"J. Parasit. Dis."},{"key":"10.1016\/j.ejps.2018.10.017_bb0410","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1007\/s11095-017-2255-7","article-title":"Pharmacokinetic and tissue distribution profile of long acting tenofovir alafenamide and elvitegravir loaded nanoparticles in humanized mice model","volume":"34","author":"Prathipati","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.10.017_bb0415","doi-asserted-by":"crossref","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i6.10","article-title":"Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic","volume":"26","author":"Puri","year":"2009","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.ejps.2018.10.017_bb0420","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejpb.2014.11.021","article-title":"Stealth anti-CD4 conjugated immunoliposomes with dual antiretroviral drugs\u2013modern Trojan horses to combat HIV","volume":"89","author":"Ramana","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2018.10.017_bb0425","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s13233-012-0107-1","article-title":"Development of solid lipid nanoparticles enriched hydrogels for topical delivery of anti-fungal agent","volume":"20","author":"Ramasamy","year":"2012","journal-title":"Macromol. Res."},{"key":"10.1016\/j.ejps.2018.10.017_bb0430","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.colsurfb.2017.03.040","article-title":"Nanoemulgel using a bicephalous heterolipid as a novel approach to enhance transdermal permeation of tenofovir","volume":"154","author":"Rambharose","year":"2017","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.ejps.2018.10.017_bb0435","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ijpharm.2013.06.015","article-title":"Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies","volume":"454","author":"Ravani","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.10.017_bb0440","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejpb.2004.03.019","article-title":"In situ-forming hydrogels\u2014review of temperature-sensitive systems","volume":"58","author":"Ruel-Gariepy","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2018.10.017_bb0445","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2174\/156720112802650707","article-title":"Comparative studies of lamivudine-zidovudine nanoparticles for the selective uptake by macrophages","volume":"9","author":"Sankar","year":"2012","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejps.2018.10.017_bb0450","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.addr.2009.11.024","article-title":"Nanotechnology applied to the treatment of malaria","volume":"62","author":"Santos-Magalh\u00e3es","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2018.10.017_bb0455","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-3565(24)29390-3","article-title":"In vivo synergistic interaction of liposome-coencapsulated gentamicin and ceftazidime","volume":"298","author":"Schiffelers","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2018.10.017_bb0460","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/jac\/dkh411","article-title":"Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral\/aerosolized antitubercular drug carriers for treatment of tuberculosis","volume":"54","author":"Sharma","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2018.10.017_bb0465","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ijantimicag.2004.07.010","article-title":"Chemotherapeutic efficacy of poly (dl-lactide-co-glycolide) nanoparticle encapsulated antitubercular drugs at sub-therapeutic dose against experimental tuberculosis","volume":"24","author":"Sharma","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejps.2018.10.017_bb0470","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1021\/nl102184c","article-title":"Nanotechnology in drug delivery and tissue engineering: from discovery to applications","volume":"10","author":"Shi","year":"2010","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejps.2018.10.017_bb0475","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1089\/aid.2012.0301","article-title":"Polymeric nanoparticles containing combination antiretroviral drugs for HIV type 1 treatment","volume":"29","author":"Shibata","year":"2013","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.ejps.2018.10.017_bb0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2191-219X-3-8","article-title":"About inflammation and infection","volume":"3","author":"Signore","year":"2013","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.ejps.2018.10.017_bb0485","first-page":"105","article-title":"The role of nanotechnology in the treatment of viral infections","volume":"4","author":"Singh","year":"2017","journal-title":"Ther. Adv. Infect. Dis."},{"key":"10.1016\/j.ejps.2018.10.017_bb0490","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejps.2016.12.011","article-title":"Hydrazone linkages in pH responsive drug delivery systems","volume":"99","author":"Sonawane","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.10.017_bb0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(00)00339-4","article-title":"Biodegradable polymeric nanoparticles as drug delivery devices","volume":"70","author":"Soppimath","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2018.10.017_bb0500","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination therapy for treatment of infections with gram-negative bacteria","volume":"25","author":"Tamma","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejps.2018.10.017_bb0505","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1016\/j.biomaterials.2011.05.038","article-title":"Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles","volume":"32","author":"Toti","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2018.10.017_bb0510","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s12936-017-2102-7","article-title":"When it just won't go away: oral artemisinin monotherapy in Nigeria, threatening lives, threatening progress","volume":"16","author":"Ujuju","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.ejps.2018.10.017_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2018.03.014","article-title":"Co-nanoencapsulation of antimalarial drugs increases their in vitro efficacy against Plasmodium falciparum and decreases their toxicity to Caenorhabditis elegans","volume":"118","author":"Velasques","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.10.017_bb0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chemphyslip.2018.05.001","article-title":"Fatty acid conjugated pyridinium cationic amphiphiles as antibacterial agents and self-assembling nano carriers","volume":"214","author":"Walvekar","year":"2018","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.ejps.2018.10.017_bb0525","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.colsurfb.2012.05.006","article-title":"Preparation and stability study of norfloxacin-loaded solid lipid nanoparticle suspensions","volume":"98","author":"Wang","year":"2012","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.ejps.2018.10.017_bb0530","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejpb.2013.08.013","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for pulmonary application: a review of the state of the art","volume":"86","author":"Weber","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2018.10.017_bb0535","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI21682","article-title":"Antimalarial drug resistance","volume":"113","author":"White","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2018.10.017_bb0540","author":"WHO"},{"key":"10.1016\/j.ejps.2018.10.017_bb0545","author":"WHO"},{"key":"10.1016\/j.ejps.2018.10.017_bb0550","author":"WHO"},{"key":"10.1016\/j.ejps.2018.10.017_bb0555","author":"WHO"},{"key":"10.1016\/j.ejps.2018.10.017_bb0560","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nature.2017.21550","article-title":"The drug-resistant bacteria that pose the greatest health threats","volume":"543","author":"Willyard","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2018.10.017_bb0565","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJMp1101548","article-title":"Development of novel combination therapies","volume":"364","author":"Woodcock","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2018.10.017_bb0570","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nmat2444","article-title":"Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA","volume":"8","author":"Woodrow","year":"2009","journal-title":"Nat. Mater."},{"key":"10.1016\/j.ejps.2018.10.017_bb0575","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1631\/jzus.B0820047","article-title":"Solid lipid nanoparticles loading adefovir dipivoxil for antiviral therapy","volume":"9","author":"Xing-Guo","year":"2008","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.ejps.2018.10.017_bb0580","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","article-title":"Nanoparticles in medicine: therapeutic applications and developments","volume":"83","author":"Zhang","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2018.10.017_bb0585","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2174\/092986710790416290","article-title":"Development of nanoparticles for antimicrobial drug delivery","volume":"17","author":"Zhang","year":"2010","journal-title":"Curr. Med. Chem."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718304640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718304640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:47:43Z","timestamp":1760528863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098718304640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":117,"alternative-id":["S0928098718304640"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2018.10.017","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination drug therapy via nanocarriers against infectious diseases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2018.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}